Naloxone hydrochloride is the hydrochloride salt of naloxone, a thebaine derivate with antagonistic role of opioids. Naloxone binds to opioid receptors in the Central Nervous System in a competitive manner, reversing or inhibiting characteristic opioid effects, including euphoria, analgesia, sedation, respiratory depression, bradycardia, miosis, and physical dependence. This agent binds to mu-opioid receptors with a high affinity and a lesser degree to kappa- and gamma-opioid receptors. Naloxone can be used to reverse opioid depression entirely or partially, including moderate to extreme respiratory depression caused by natural and synthetic opioids, the agonists/antagonists nalbuphine and pentazocine, or dextropropoxyphene. It may also be used for the diagnosis of suspected acute opioid overdosage. Naloxone may be used to counteract respiratory and other CNS depression in the newborn resulting from the administration of analgesics to the mother during childbirth.
Factors driving the growth of the naloxone hydrochloride market are the growing prevalence of opioid overdose, coupled with rising number of victims with dependency on opioid. However, the high cost of and side effects of naloxone hydrochloride is expected to hamper the growth of the market. Moreover, growing dependency on opioids and rising investments by major market players in naloxone hydrochloride is anticipated to boost the market growth.
The "Naloxone Hydrochloride Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of naloxone hydrochloride market with detailed market segmentation by type and application. The naloxone hydrochloride market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in naloxone hydrochloride market and offers key trends and opportunities in the market.
The naloxone hydrochloride market is segmented on the basis of type and application. Based on type, the market is segmented as More than 98% and Less than 98%. On the basis of application, the market is categorized as injection, tablets, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the naloxone hydrochloride market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The naloxone hydrochloride market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting naloxone hydrochloride market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the naloxone hydrochloride market in these regions.
Get more information on this report :
The report covers key developments in the naloxone hydrochloride market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from naloxone hydrochloride market are anticipated to have lucrative growth opportunities in the future with the rising demand for naloxone hydrochloride in the global market. Below mentioned is the list of few companies engaged in the naloxone hydrochloride market.
The report also includes the profiles of key players in naloxone hydrochloride market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
VAV Life Sciences
Gaobo Jingband Pharmaceutical
Aoxing Group Pharmaceutical
Johnson Matthey PLC
Faran Shimi Pharmaceutical Company
Micro Orgo Chem
Resonance Laboratories Pvt. Ltd
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
The List of Companies
1. Sun Pharmaceutical
3. VAV Life Sciences
4. Xinhua Pharm
6. Gaobo Jingband Pharmaceutical
7. PUAN Pharmaceutical
8. Aoxing Group Pharmaceutical
9. Teva Pharmaceutical
10. Nhwa Pharmaceutical
11. Easton Biopharmaceuticals
13. Mallinckrodt Plc
14. Temad Co
15. Johnson Matthey PLC
16. Faran Shimi Pharmaceutical Company
17. Micro Orgo Chem
18. Resonance Laboratories Pvt. Ltd
19. Rusan Pharma
20. Siegfried AG